"10.1371_journal.pone.0113533","plos one","2014-12-01T00:00:00Z","Martine Dubois; Vadim Le Joncour; Marie-Christine Tonon; Youssef Anouar; François Proust; Fabrice Morin; Pierrick Gandolfo; Florence Joly; Pascal Hilber; Hélène Castel","Inserm U982, Laboratory of Neuronal and Neuroendocrine Communication and Differentiation (DC2N), Astrocyte and Vascular Niche, University of Rouen, Mont-Saint-Aignan, France; PRES Normandie Université, Institute of Research and Biomedical Innovation (IRIB), University of Rouen, Mont-Saint-Aignan, France; North-West Cancéropole (CNO), Lille, France; EA4700, Laboratory of Psychology and Neurosciences of Cognition and Affectivity (PSY-NCA), University of Rouen, Mont-Saint-Aignan, France; Centre François Baclesse, Caen, France; Centre Hospitalo-Universitaire, Caen, France","Conceived and designed the experiments: HC PG FM FP. Performed the experiments: MD VL M-CT. Analyzed the data: HC MD FJ. Contributed reagents/materials/analysis tools: PH YA. Wrote the paper: MD HC.","The authors have read the journals policy and have the following conflict: The Grant to the baclesse Center of Caen, France, by Novartis (Novartis- 071160-31 001141-05) was a general educational grant and was used to support a post-doc leading the research on everolimus. In addition, the authors received everolimus and the microemulsion through an MTA with Novartis. Pr Florence Joly is a member of a consulting scientific board of Novartis. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","12","Martine Dubois","MD",10,TRUE,4,3,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
